Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

FibroScan: M probe underestimates hepatic fat content

Publish date:: June 12, 2020

Key clinical point: Using an M probe for transient elastography (FibroScan) may underestimate hepatic fat content.

Major finding: The mean controlled attenuation parameter measured by the XL probe was 317 dB/m, compared with 310 dB/m for the M probe (P = .007).

Study details: A prospective study involving 100 adults with and without nonalcoholic fatty liver disease.

Disclosures: The study was funded by Atlantic Philanthropies, the John A. Hartford Foundation, the American Gastroenterological Association, and others. The investigators disclosed no conflicts of interest.

Citation:

Caussy C et al. Clin Gastro Hepatol. 2019 Dec 13. doi: 10.1016/j.cgh.2019.11.060.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Hepatology

Endoscopic intragastric balloon improved NASH parameters,

Pronounced racial differences in HBsAg loss after stopping nucleos(t)ide,

HCC rates slow in cities, continue to climb in rural areas,

Liquid biopsy captures key NASH pathology hallmarks,